Capricor Therapeutics amends charter to extend officer exculpation under DGCL

CAPRICOR THERAPEUTICS, INC.

Stockholders approved the amendment on June 12, 2023.
Certificate of Amendment filed with Delaware Secretary of State on June 13, 2023, effective same day.
Amendment extends exculpation of monetary liability to officers for breach of fiduciary duty, as permitted by DGCL Section 102(b)(7).
Previously only directors were exculpated; change aligns with Delaware law update effective August 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

CAPRICOR THERAPEUTICS, INC.: Amended the Certificate of Incorporation to add exculpation of officers for monetary damages for breach of fiduciary duty, as permitted by Delaware law (effective 2023-06-13).

Change: charter amendment
Effective: 2023-06-13

Exact text from the filing

On June 13, 2023, the Company filed a Certificate of Amendment of Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect the Amendment, effective as of June 13, 2023.

View on SEC.gov

190 governance changes filed in the last 30 days. Browse all governance changes →

CAPRICOR THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001558370-23-011050

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.